About Us
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Strategic Advisors
Technology
Our Technology
For Researchers
Pipeline
SQZ Pipeline
SQZ APC PLATFORM
SQZ AAC PLATFORM
SQZ TAC PLATFORM
Patients
Investors
Overview
News
Events & Presentations
Publication, Presentations, & Posters
Stock Info
SEC Filings
Financials
Governance
Resources
Join Us
#HowCellsWork
SQZ
BIOTECH
Empowering Cells to Change Lives
A clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions.
Technology
Therapeutic
Platforms
Pipeline
Latest News
June 21, 2022
Poster:
SQZ® TAC Cell Therapy Platform Induces Antigen Specific T-regs and Prevents Onset of Type 1 Diabetes in Adoptive Transfer Models
June 21, 2022
SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
June 16, 2022
SQZ Biotechnologies Announces Generation of Dopaminergic Neurons from Human Pluripotent Stem Cells Through Single-Step Delivery of Six Cell-Fate Encoding RNAs
View All News
Join The Team
Learn More